State Action
CCAGW Urges South Carolina Legislators to Support H. 5118
H. 5118 would streamline the regulatory appeals and approval processes for applications to build new energy transmission infrastructure.
CCAGW Urges Kentucky Senators to Oppose SB 188
SB 188 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers (PBMs) in Kentucky.
CCAGW Urges Virginia Legislators to Oppose Senate Bill 119
SB 119 would make changes to the federal 340B drug discount program.
CCAGW Urges Mississippi Legislators to Oppose House Bill 728
HB 728 would make changes to the federal 340B drug discount program operates in the Magnolia State.
CCAGW Urges Support of Sen DeBoer Amendment to LB 61
DeBoer amendment would raise the broadband speed threshold to 100/20 Mbps for unserved communities.
CCAGW Urges Nebraska Legislators to Oppose LB 61
Nebraskans should not be obligated to support government funded broadband networks when they are built in direct competition against existing providers.
CCAGW Urges Virginia Senators to Oppose Senate Bill 274
SB 274 would impose price controls on prescription drugs.
CCAGW Urges South Carolina Legislators to Oppose Senate Bill 910
SB 910 would effectively ban short-term lending for borrowers throughout the state.
CCAGW Urges Virginia Senators to Oppose Senate Bill 274
SB 274 which would impose price controls on prescription drugs.
CCAGW Urges Indiana Legislators to Oppose Senate Bill 3
SB3 would ban PBMs from utilizing formularies to reduce patient costs.
CCAGW Urges West Virginia Legislators to Oppose Senate Bill 325
SB 325 would make changes to the federal 340B drug discount program.
CCAGW Urges West Virginia Legislators to Oppose SB 325
SB 325 would change how the federal 340B program operates in the Mountain State.